Tripping Over Trump: Will the New Administration Embrace Psychedelic Exceptionalism or ‘Just Say No’? Post published:November 14, 2024 Post category:Analysis/News
Question 4 Fails: Massachusetts Says No to State-Regulated Psychedelics Access and Decriminalisation Post published:November 6, 2024 Post category:Analysis/News
Psychedelics Advocates Urge Yes on Question 4 Amid Last-Minute Debates Post published:November 4, 2024 Post category:Analysis/News
Bipartisan Momentum or Radical Reform? Insiders Weigh In on the Future of Psychedelic Research and Regulation Under Trump or Harris Post published:November 4, 2024 Post category:Analysis/News/Pα+
Backed by $15m in NIDA Funding, NYU and B.More Team Up to Trial Psilocybin for Opioid Use Disorder Post published:October 31, 2024 Post category:Analysis/News/Pα+
Compass Pathways Pushes Back Phase 3 Readouts, Lays Off 30% of Staff Post published:October 31, 2024 Post category:Analysis/News/Pα+
Final Stretch for Question 4: Controversy, Advocacy, and Celebrity Voices Shape Psychedelic Vote Post published:October 28, 2024 Post category:Analysis/News
Psychedelics Take Centre Stage in Massachusetts’ Local Media Post published:October 21, 2024 Post category:Analysis/News
Massachusetts Psychiatrists Push Back on Psychedelic Reform as Ballot Vote Looms: An Interview with Nassir Ghaemi Post published:October 10, 2024 Post category:Analysis/News